Join
Live feed
·
PRReleasevia Quantisnow
Bristol-Myers Squibb Company logo
BioNTech SE logo

Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

ByQuantisnow·Wall Street's wire, on your screen.
BMY· Bristol-Myers Squibb CompanyBNTX· BioNTech SE
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BMY (Bristol-Myers Squibb Company), BNTX (BioNTech SE) and more on Quantisnow.